Additional Proxy Soliciting Materials (definitive) (defa14a)
April 26 2017 - 4:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
INFORMATION
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant ☒ Filed by a party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Under § 240.14a-12
|
Clovis
Oncology, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing party:
|
|
|
(4)
|
|
Date Filed:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*** Exercise Your
Right
to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 08, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Meeting Information
|
|
|
|
|
CLOVIS ONCOLOGY, INC.
|
|
|
|
|
|
Meeting Type:
Annual Meeting
|
|
|
|
|
|
|
|
|
|
|
For holders as of:
April 10, 2017
|
|
|
|
|
|
|
|
|
|
|
Date:
June 08, 2017
Time:
8:30 AM MDT
|
|
|
|
|
CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY
BOULDER, CO 80301
|
|
|
|
|
|
Location:
The St. Julien Hotel
|
|
|
|
|
|
|
|
|
900 Walnut
Street
Boulder, CO
80302
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You are receiving this communication because
you hold shares in the above named company.
This is not a ballot. You cannot use this
notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper
copy (see reverse side).
We encourage you to access and review all of the important
information contained in the proxy materials before voting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See the reverse side of this notice to obtain proxy materials and voting
instructions.
|
|
|
Before You Vote
How to Access the Proxy Materials
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proxy Materials Available to VIEW or RECEIVE:
1. Notice & Proxy Statement 2.
Annual Report on Form 10K 3. Telephone/Internet insert (BR supplied)
How to View Online:
Have the information that is printed
in the box marked by the arrow
(located on the following page) and visit:
www.proxyvote.com.
How to Request and Receive a PAPER or
E-MAIL
Copy:
If you want to receive a paper or
e-mail
copy of these documents, you must request one. There is NO charge for
requesting a copy. Please choose one of the following methods to make your request:
1)
BY INTERNET
: www.proxyvote.com
2)
BY TELEPHONE
:
1-800-579-1639
3)
BY
E-MAIL*
:
sendmaterial@proxyvote.com
* If requesting materials by
e-mail,
please send a blank
e-mail
with the
information that is printed in the box marked by the arrow
(located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this
e-mail
address will NOT be forwarded to your investment
advisor. Please make the request as instructed above on or before May 25, 2017 to facilitate timely delivery.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How To
Vote
Please Choose One of the Following Voting Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
Vote In Person:
Many stockholder meetings have attendance requirements including, but not limited to, the possession of an attendance
ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
|
|
|
|
|
|
Vote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have
the information that is printed in the box marked by the arrow
available and follow the instructions.
Vote By
Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends you vote FOR the following proposal
:
|
|
|
|
|
|
|
|
|
1.
|
|
Election of three Class III directors to hold office until the 2020 Annual Meeting of Stockholders.
|
|
|
|
|
|
|
|
|
|
|
Nominees
|
|
|
|
|
|
|
|
01
|
|
Keith Flaherty, M.D. 02 Ginger L.
Graham 03 Edward J. McKinley
|
|
|
|
|
The Board of Directors recommends you vote FOR the following:
|
|
|
|
|
|
2.
|
|
Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2017.
|
|
|
|
|
NOTE:
In their discretion, the proxies are authorized to vote on such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
|
|
|
|
|
|
|
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024